Revised. Amendments from Version 1
==================================

In this revision, we have summarized additional studies that apply machine learning to identifying biomarkers of radiation exposure (requested by Drs. Quintens and Mysara). We corrected the text to address their comment that *Glipr2* did not occur more frequently than *Ms4a1*in the murine gene signatures (this was an oversight, since the original Figure 3 was correct). For clarity, we have highlighted *Eif2ak4* and *Ccng1,* rather than *Glipr2*. Based on a reader's suggestion, we have also determined the accuracy of the human signatures we derived for detection of partial body irradiation exposures. The human signatures have been validated on a partial body radiation gene expression dataset in an experimental baboon primate model (GEO: GSE77254).  The revised paper includes a description of this dataset and the results of this analysis.

Introduction
============

Potential radiation exposures from industrial nuclear accidents, military incidents, or terrorism are threats to public health ^[@ref-1]^. There is a need for large scale biodosimetry testing, which requires efficient screening techniques to differentiate exposed individuals from non-exposed individuals and to determine the severity of exposure ^[@ref-2]^. Current diagnostic techniques, including the cytogenetic gold standard ^[@ref-3]--\ [@ref-6]^, may require several days to provide accurate dose estimates ^[@ref-1],\ [@ref-7]^ of large cohorts. To address the need for faster diagnostic techniques that accurately measure radiation exposures, gene signatures based on transcriptomic data have been introduced ^[@ref-7]--\ [@ref-10]^. Probit regression models of radiation response using 25 probes on peripheral blood samples achieved up to 90% accuracy for distinguishing between irradiated blood samples and unirradiated controls ^[@ref-9]^. A 74-gene classifier based on nearest centroid expression levels was 98% accurate in distinguishing four levels of irradiation from controls ^[@ref-10]^. This level of performance implies that samples exposed to different levels of radiation may be distinguishable based on mRNA expression levels of different genes. While this suggests the feasibility of transcriptional modeling of radiation responses, validation with external datasets is required to establish its reliability for rapid diagnostics. A caveat of these signatures is that they have not all been externally validated on datasets independent of the source data used for model development. A 29-gene signature modelled using a support vector machine (SVM) was externally validated on such a dataset, resulting in 80% accuracy in distinguishing higher (≥8Gy) from lower dose (≤2Gy) radiation exposure in novel samples ^[@ref-7]^. Previous studies have identified biomarkers that distinguish irradiated ( *ex vivo*) from unirradiated blood samples with high accuracies ^[@ref-11]--\ [@ref-15]^. The present study derives signatures with improved performance on externally validated samples by employing a different selection of modelling techniques. The machine learning pipeline used here addresses some of the previous limitations through a more rigorous feature selection process and stricter validation procedures.

Previously, the Student's t-test ^[@ref-7]^, the F-test ^[@ref-10]^, and correlation coefficients ^[@ref-9]^ were used to identify potential radiation biomarker genes. Although statistical criteria can distinguish genes that are differentially expressed upon radiation exposure, they do not eliminate expressed genes with redundant responses to radiation exposure. Redundancy increases the possibility of overfitting, thereby reducing the generalizability of these models to predict responses in independent datasets. We address this limitation with the information theory-based criterion for gene selection known as minimum redundancy maximum relevance (mRMR) ^[@ref-16]--\ [@ref-18]^, which ranks genes according to shared mutual information between expression levels and radiation dose (relevance), and by minimizing mutual information shared by expression values of these and other genes (redundancy) ^[@ref-17],\ [@ref-18]^. mRMR outperforms ranking criteria based solely on maximizing relevance ^[@ref-17]^. In contrast with heuristic approaches like differential expression, we only consider genes with evidence of a relationship to radiation response, which significantly limits the number of model features. Biochemically-inspired genomic machine learning (ML) has been used to derive high performing gene signatures that predict chemotherapy and hormone therapy responses ^[@ref-18]--\ [@ref-20]^. From an initial set of mRMR-derived biochemically relevant genes, wrapper approaches for feature selection ^[@ref-21]^ are used to find an optimal set of genes that predict exposure to radiation.

It can be challenging to obtain highly accurate models that perform well on externally validated samples for several reasons. Aside from biases in training data, batch effects and lack of reproducibility may introduce systematic and random sources of variability into gene expression microarray data. Different source datasets can impact data normalization, reducing model performance. We utilize two validation procedures. The first is a signature-centric approach that mirrors external k-fold validation ^[@ref-7]^. The limitation of signature-centric validation is that, while signatures allow for the identification of important genes associated with radiation response, a tangible model is required to generate actual diagnostic predictions. To address this limitation, we also use a second model-centric approach, which we term "traditional validation". This procedure applies quantile normalization to training and test data before a model is fitted to the training data. This quantile method has been shown to be more effective than scaling, loess, contrast, and non-linear methods in reducing variation between microarray data ^[@ref-22]^. Model validation was not expected to perform as well as signature validation, because quantile normalization is not always successful in eliminating variation between microarray datasets, whereas k-fold validation is independent of this source of variation. This study shows that robust model validation is a critical step in reproducibly predicting which individuals have been exposed to significant levels of radiation.

Methods
=======

Datasets
--------

Murine gene expression datasets ^[@ref-23]^ were obtained from peripheral blood (PB) mononuclear cell samples of ten-week old C57B16 mice that either received total body radiation at 50 cGy, 200 cGy, or 1000 cGy or were not exposed. Post-exposure, total RNA was isolated after 6 hours and expression was determined by microarray analysis using Operon Mouse V3.0.1 (Gene Expression Omnibus (GEO): GPL4783 from GSE10640\[GPL4783\]) ^[@ref-24]^ and Operon Mouse V4.0 arrays (GEO: GPL6524 from GSE10640\[GPL6524\]) ^[@ref-24]^. Similar analyses were performed with human expression microarrays ^[@ref-18]^, including datasets GEO: GSE6874\[GPL4782\] ^[@ref-9]^, GSE10640\[GPL6522\] ^[@ref-24]^, GSE1725 ^[@ref-25]^, and GSE701 ^[@ref-26]^. GSE6874 and GSE10640 consist of PB samples collected 6 hours post-exposure from healthy donors and patients undergoing total body irradiation at 150--200 cGy analyzed with Operon Human V3.0.2 (GEO: GPL4782) and Operon Human V4.0 (GEO: GPL6522) microarrays. GSE10640\[GPL6522\] consists of 32 patients treated with alkylator-based chemotherapy without radiation. GSE1725 contains lymphoblastoid cell line samples derived from 57 subjects treated with 500 cGy. RNA was extracted 4 hours after exposure. Expression was measured using Affymetrix Human Genome U95 Version 2 Array (GEO: GPL8300). GSE701 contains lymphoblastoid cell lines from Fondation Jean Dausset-CEPH which were irradiated at 300 cGy or 1000 cGy and extracted 1--24 hours after exposure. Expression was measured using the Affymetrix Human Genome U95A Array (GEO: GPL91). The GSE77254 dataset ^[@ref-27]^ was also used to validate our human signatures. This dataset consisted of blood samples collected from baboons that were either total body or partial body irradiated with Cobalt 60 at either 2.5 or 5 Gy. Expression for each subject was measured 1 to 2 days after exposure and was related to their hematologic acute radiation syndrome (HARS) scores.

Preprocessing ( [Figure 1](#f1){ref-type="fig"}, panel i)
---------------------------------------------------------

Rows and columns of microarray data that are less than 95% complete were removed and any remaining missing values were imputed using the nearest-neighbor algorithm. Only genes that are common across all datasets have been retained. Expression values of each probe were transformed to z-scores and the mean expression value of probes for the same gene have been assigned as the expression of each gene. Human and murine signatures were derived separately.

![Flow chart of the biochemically inspired machine learning pipeline used to derive gene signatures.\
In panel (v), k-fold validation splits data into k sections, where each section acts as a test set in turn while the remaining sections act as a training set. Panel (v) depicts k-fold validation for *k* = 3. Coloured circles represent the samples in a dataset where different colours represent different radiation doses. In panel (vi), quantile normalization forces data into the same distribution. To demonstrate this, thirty random genes were chosen to form a signature. The histograms on the left represent the distributions of expression levels of these genes in the pre-normalized datasets GSE1725 and GSE6874\[GPL4782\]. The histograms on the right represent the distribution of expression levels of the same genes post-normalization.](f1000research-7-16666-g0000){#f1}

Biochemically-inspired gene selection ^[@ref-18]--\ [@ref-20]^ ( [Figure 1](#f1){ref-type="fig"}, panel ii)
-----------------------------------------------------------------------------------------------------------

A literature search has been conducted to identify genes implicated in radiation response using the search queries "radiation genes," "radiation response genes," and "radiation signatures" on PubMed. Cited genes comprise those differentially expressed after radiation exposure, genes present in DNA repair databases and other radiation signatures, and evolutionarily conserved genes that were highly expressed in radio-resistant species. A list of 998 genes was compiled ^[@ref-28]--\ [@ref-41]^, [Supplementary Table X](#SF1){ref-type="other"}) for deriving signatures.

Minimum Redundancy Maximum Relevance (mRMR) gene ranking ^[@ref-11],\ [@ref-12]^ ( [Figure 1](#f1){ref-type="fig"}, panel iii)
------------------------------------------------------------------------------------------------------------------------------

Rank is assigned by incremental selection of genes based on the mutual information difference (MID) criterion ^[@ref-16],\ [@ref-17]^. Highly ranked genes have expression information that shares mutual information with radiation exposure and shares little information with expression of other genes. The MID criterion used to select the next ranked gene is ${\text{max}}_{\text{i} \in \Omega}\left\lbrack {I(i,h) - \frac{1}{\left| S \right|}{\sum_{j \in S}{I(i,j)}}} \right\rbrack,$ where *i* is a gene selected from *Ω*, the total gene space, *S* is the set of genes selected before *i*, \| *S*\| is the number of genes selected before *i*, *I*( *i*, *h*) is the mutual information between expression of gene *i* and radiation dose ( *h*), and *I*( *i*, *j*) is the mutual information between expression of gene *i* and expression of gene *j*.

Support Vector Machine (SVM) Learning
-------------------------------------

SVM models are classifiers that use hyperplane boundaries to separate samples into exposure classes by maximizing the distance between the separating hyperplanes and samples of each class. The *fitcecoc* function of MATLAB 2017a's Statistics and Machine Learning Toolbox ^[@ref-42]^ with a SVM template was used to fit SVM models to training data. The *fitcecoc* function was used because it allows the fitting of multiclass models, which was required for analysis of murine samples that were irradiated at four different exposure levels. The SVM models use the Gaussian radial basis function kernel and a range of selected box-constraint and kernel-scale parameters. The box-constraint, denoted by the variable *C*, determines how severely misclassifications are penalized during training. The kernel-scale, denoted *σ*, represents the width of the Gaussian radial basis function. These parameters collectively control the tradeoff between underfitting and overfitting ^[@ref-43]^. After feature selection, a grid search is performed to determine the optimal ( *C*, *σ*) combination for values of *C* and *σ* between 1 and 100000 (inclusive) by powers of 10 such that *C* ≥ *σ*.

Feature selection (FS) ( [Figure 1](#f1){ref-type="fig"}, panel iv) ^[@ref-21]^
-------------------------------------------------------------------------------

Greedy feature selection was used to derive signatures. Complete sequential feature selection (CSFS) sequentially adds genes to an initially empty base set. The added gene is the highest mRMR-ranked gene that is not already included. This is repeated until all genes have been evaluated and the best performing subset of genes is identified. Forward sequential feature selection (FSFS) sequentially adds genes from the top 50 mRMR ranked genes to an initially empty base set. The added gene is the one whose addition improves the model by the greatest margin. Backward sequential feature selection (BSFS) sequentially removes genes from the top 30 mRMR ranked genes. The gene removed is the one whose removal causes the greatest improvement in the model. For BSFS and FSFS, we measure model improvement using misclassification or log loss during k-fold validation (see *Performance metrics* section below). Genes are added or removed until model performance plateaus. During feature selection, *C* and *σ* parameters need to be chosen for SVM learning (see *SVM Learning* section above). Thus, each signature is characterized by the feature selection algorithm used, the dataset used to derive it, and the *C*- *σ* combination used for its SVM models during feature selection. This leads to a large number of possible signatures (see [Supplementary Files Y1--Y7](#SF2){ref-type="other"}). [Supplementary Files Y1--Y3](#SF2){ref-type="other"} and [Supplementary Files Y6--Y7](#SF2){ref-type="other"} contain k-fold validation results from which the top 20 signatures (evaluated using average validation log loss), in particular, were analyzed ( [Figure 2](#f2){ref-type="fig"}, [Figure 3](#f3){ref-type="fig"}, [Figure 6](#f6){ref-type="fig"}, [Figure 7](#f7){ref-type="fig"}).

![Heat map depicting the gene compositions of the top 20 murine signatures derived from different datasets: GSE6874\[GPL4783\] and GSE10640\[GPL6524\].\
Gene frequency values are first scaled within datasets and then scaled across datasets to ensure values between 0 and 1.](f1000research-7-16666-g0001){#f2}

![Scatter plot depicting the mutual information each gene's expression shares with radiation exposure (averaged over GSE6874\[GPL4783\] and GSE10640\[GPL6524\]).\
The size of each circle is proportional to the frequency at which the gene appears in the top 20 murine signatures ranked by log loss averaged over GSE6874\[GPL4783\] and GSE10640\[GPL6524\]. The genes presented match those of the [Figure 2](#f2){ref-type="fig"}.](f1000research-7-16666-g0002){#f3}

Validating signatures ( [Figure 1](#f1){ref-type="fig"}, panel v)
-----------------------------------------------------------------

Stratified k-fold validation was used to validate signatures. Samples of the validation dataset were partitioned into *k* sets, comprised of an approximately equal distribution of radiation levels. For validation, each set was used to test a model trained on the remaining sets, resulting in predictions for all samples in the dataset. Advantages of this approach are that variation between datasets is not pertinent and that signatures can be validated on differently labeled datasets (with samples irradiated at different levels).

Validating models ( [Figure 1](#f1){ref-type="fig"}, panel vi)
--------------------------------------------------------------

Model validation requires separate training and test datasets (the training set is often used for FS). Genes from the signature are extracted from the training and test sets and their expression values are quantile normalized by sample. An important distinction between our approach and a previous study ^[@ref-7]^ is that quantile normalization is applied immediately before validation, so expression of only the genes present in the signature being validated have been normalized. By contrast, previous approaches perform quantile normalization over entire datasets; while this reduces variability in expression values within datasets, it also suppresses the dynamic range, with potential consequential effects on the prognostic value of expression data. After normalization, an SVM model was fit to training datasets and used to generate predictions from the test dataset.

Performance metrics ( [Figure 1](#f1){ref-type="fig"}, panel vii)
-----------------------------------------------------------------

Performance was determined by comparing predicted radiation doses with actual radiation exposures of each sample. Metrics included misclassification error rate, goodness-of-fit, and multi-class log loss. Misclassification is the percentage of samples that were incorrectly classified, goodness-of-fit is the average absolute value difference between predicted radiation exposure and actual radiation exposure, and multi-class log loss is $- \frac{1}{N}{\sum_{i = 1}^{N}{\sum_{j = 1}^{M}y_{ij}}}\text{ln}p_{ij}$ where *N* is the number of samples, *M* is the number of class labels, *p* ~*ij*~ is the predicted probability that observation *i* is in class *j*, and *y* ~*ij*~ is an indicator variable equal to 1 if sample *i* is in class *j* and 0 otherwise.

Results
=======

We discovered radiation gene signatures using the microarray data of human and mouse peripheral blood samples and human lymphoblastoid cell lines, which were validated either according to signature ( [Figure 1](#f1){ref-type="fig"}, panel v) or with the respective model ( [Figure 1](#f1){ref-type="fig"}, panel vi). The murine data were obtained from a wider range of radiation exposure levels (0 cGy, 50 cGy, 200 cGy, 1000 cGy) than the human whole body radiation datasets, which were binary comparisons of radiation effects (0 cGy vs. 150-200 cGy, 0 cGy vs. 500 cGy, or 300 cGy vs. 700 cGy). This made possible the discovery of murine gene signatures with finer granularity for discriminating individuals exposed to different exposure levels, which is not currently feasible with the human samples.

Murine gene signatures
----------------------

[Table 1](#T1){ref-type="table"} displays the murine signatures derived using our pipeline which had the best performance metrics during k-fold validation on an independent dataset. In addition to the signature information, we report the feature selection algorithm ( [FS Algo]{.ul}rithm) used to discover the signature, the internal validation performance metrics ( [FS Misclass]{.ul}ification fraction and [FS Log Loss]{.ul} function). Validation performance metrics on external dataset(s) are indicated by the [Validation Misclass]{.ul}ification fraction, [Validation Log Loss]{.ul} function, and [Validation]{.ul} goodness of fit or ( [GoF]{.ul}). In the FS Misclass. and FS Log Loss columns, one value is always N/A because signatures are derived by optimizing either misclassification or log loss, but never both. The remaining murine signatures are presented in [Supplementary Files Y6](#SF2){ref-type="other"} and [Supplementary Files Y7](#SF2){ref-type="other"}.

###### Best murine signatures assessed by K-Fold validation.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Signature ( *C, σ*)                                                                            FS ^[1](#fn1){ref-type="other"}^\   FS ^[1](#fn1){ref-type="other"}^\   FS ^[1](#fn1){ref-type="other"}^\   Validation\   Validation\   Validation\
                                                                                                 Algo.                               Misclass.                           Log\                                Misclass.     Log Loss      GoF ^[2](#fn1){ref-type="other"}^
                                                                                                                                                                         Loss                                                            
  ---------------------------------------------------------------------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ------------- ------------- -----------------------------------
  **a) Derived from GSE6874\[GPL4783\] and 5-fold Validated on GSE10640\[GPL6524\] (n = 75)**                                                                                                                                            

  *Phlda3 Blnk Bax Cdkn1a Cct3 Pold1 Cd79b Ei24*\                                                BSFS                                N/A                                 0.08                                0.08 ± 0.00   0.29 ± 0.02   15 ± 0
  *Eif2ak4 Ccng1 Glipr2 Hexb Pou2af1 Swap70*\                                                                                                                                                                                            
  *Apex1 Ptpn1 Mdm2 Tpst1 Ly6e Sdcbp* (10, 10)                                                                                                                                                                                           

  *Phlda3 Blnk Bax Cdkn1a Cct3 Tfam Pold1 Cd72*\                                                 BSFS                                0.04                                N/A                                 0.10 ± 0.00   0.23 ± 0.01   26 ± 1
  *Cd79b Ei24 Galt Eif2ak4 Ms4a1 Ccng1 Glipr2*\                                                                                                                                                                                          
  *Gga2 Sh3bp5 Hexb Gcdh Pou2af1 Swap70 Apex1*\                                                                                                                                                                                          
  *Ptpn1 Mdm2 Tpst1 Ly6e Sdcbp Lcn2 Suclg2*\                                                                                                                                                                                             
  (100000, 100)                                                                                                                                                                                                                          

  *Cdkn1a Blnk Phlda3 Sdcbp Ccng1* (1000, 100)                                                   FSFS                                N/A                                 0.13                                0.17 ± 0.00   0.49 ± 0.01   12 ± 0

  **b) Derived from GSE10640\[GPL6524\] and 6-fold Validated on GSE6874\[GPL4783\] (n = 103)**                                                                                                                                           

  *Blnk Ccng1 Tpst1 Pole4 Eif2ak4 Atp5l* (100000, 100)                                           FSFS                                N/A                                 0.12                                0.11 ± 0.00   0.35 ± 0.01   25 ± 0

  *Blnk Polk Sod3 Ube2v1 Eif2ak4* (10000, 100)                                                   FSFS                                N/A                                 0.22                                0.20 ± 0.00   0.64 ± 0.01   18 ± 0
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^FS: Feature Selection ^2^GoF: Goodness of Fit.

A list of the most consistently appearing genes in the best performing signatures were obtained by pooling the top 20 murine signatures (assessed by validation log loss) from GSE6874\[GPL4783\] and GSE10640\[GPL6524\], and respectively collating the top 17 and 19 most frequent genes. The union of these two sets comprises 33 genes displayed in a heat map based on the frequencies of each gene ( [Figure 2](#f2){ref-type="fig"}). Surprisingly, the compositions of signatures derived from both datasets are not as similar as one may expect. The genes that appear more frequently in signatures derived from one dataset infrequently appear in the other even though both datasets consisted of the same types of samples irradiated at the same exposure levels.

The shared mutual information of these expressed genes with radiation dose ( [Figure 3](#f3){ref-type="fig"}) indicates whether only high mutual information genes appear in the best signatures or whether some lower mutual information genes may also be selected by our feature selection algorithms. The frequency of each gene among these signatures (represented by diameter of the circle) correlates with the mutual information between expression and radiation dose ( *ρ* = 0.8016). However, it would be an oversimplification to create signatures based solely upon mutual information, since some genes in lower performing signatures exhibit higher mutual information content. Development of accurate signatures requires more than a collection of gene features whose individual expression values share information with radiation dose, since many of these genes may reveal similar information, and redundant machine learning model features. For instance, *Bax* and *Blnk* are both common among the best murine signatures, even though *Blnk* shares much more mutual information with radiation dose than *Bax* expression. Since *Blnk* and *Bax* are involved in completely different pathways -- *Bax* is an inducer of apoptosis ^[@ref-44]^ whereas *Blnk* is involved in a B-cell antigen receptor signaling pathway required for optimal B-cell development ^[@ref-45]^, they provide different types of information to the overall model. Conversely, we also observe that genes with high information content, such as *Ms4a1*, may appear less frequently than genes with lower information content, such as *Eif2ak4* or *Ccng1*.

Although mRMR prioritizes genes with non-redundant, complementary contributions, subsequent wrapper steps of forward and backward sequential feature selection occur independently of the mRMR ranking. mRMR reduces the list of features considered by these algorithms, but it is possible for only high mutual information genes to be selected for the final signature. Thus, the inclusion of lower mutual information genes, such as *Ube2v1* and *Urod*, reinforces the effectiveness of the mRMR method.

The cellular roles of these protein products ( [Figure 2](#f2){ref-type="fig"} and [Figure 3](#f3){ref-type="fig"}) demonstrate a variety of pathways and functions ( [Figure 4](#f4){ref-type="fig"}), some of which have previously discussed ^[@ref-46]^. These include DNA repair genes ( *Polk* ^[@ref-29]^ and *Pold1* ^[@ref-32]^), inducers of apoptosis ( *Ei24* ^[@ref-36]^, *Bax* ^[@ref-36]^, and *Phlda3* ^[@ref-36]^), chaperonins ( *Cct3* ^[@ref-28]^ and *Cct7* ^[@ref-28]^), cell cycle regulators ( *Ccng1* ^[@ref-33]^ and *Cdkn1a* ^[@ref-36]^), B-cell development genes ( *Cd79b* ^[@ref-24]^ and *Blnk* ^[@ref-24]^), B-cell antigens ( *Cd72* ^[@ref-9]^ and *Ms4a1* ^[@ref-24]^), and a stress-response kinase that inhibits protein synthesis globally ( *Eif2ak4* ^[@ref-31]^).

![Depiction of the major cellular functions of most frequently appearing genes of the best murine signatures (same genes presented in [Figure 1](#f1){ref-type="fig"} and [Figure 2](#f2){ref-type="fig"}).](f1000research-7-16666-g0003){#f4}

One of the best murine signatures derived from GSE10640\[GPL4783\]: *Phlda3*, *Blnk*, *Bax*, *Cdkn1a*, *Cct3*, *Pold1*, *Cd79b*, *Ei24*, *Eif2ak4*, *Ccng1*, *Glipr2*, *Hexb*, *Pou2af1*, *Swap70*, *Apex1*, *Ptpn1*, *Mdm2*, *Tpst1*, *Ly6e*, *Sdcbp* consistently achieved \<10% misclassification error with SVM parameters *C* = 10, *σ* = 10. However, for samples that are incorrectly classified according to this signature, the misclassification percentage does not reveal the actual deviation from the correct dose. The confusion matrix visualizes the prediction accuracy of this signature on GEO: GSE10640\[GPL6524\] ( [Figure 5](#f5){ref-type="fig"}). Indeed, the performance of the matrix shows that the predicted errors for a small fraction of samples deviate from the actual exposures by no more than a single adjacent exposure level. Although the predictions presented in the confusion matrix come from a single iteration of k-fold validation, the standard error associated with misclassification for this signature is extremely low (0.0013) so this confusion matrix is representative of nearly all possible iterations of k-fold validation.

![Confusion matrix for murine signature: *Phlda3*, *Bax*, *Cdkn1a*, *Cct3*, *Tfam*, *Pold1*, *Cd72*, *Cd79b*, *Ei24*, *Galt*, *Eif2ak4*, *Ms4a1*, *Ccng1*, *Glipr2*, *Gga2*, *Sh3bp5*, *Hexb*, *Gcdh*, *Pou2af1*, *Swap70*, *Apex1*, *Ptpn1*, *Mdm2*, *Tpst1*, *Ly6e*, *Sdcbp*, *Lcn2*, *Suclg2*.\
Numerators represent the number of samples in each category while denominators represent the total number of samples that were irradiated at a given exposure level (i.e. is the sum of the number of samples in each row).](f1000research-7-16666-g0004){#f5}

Human gene signatures
---------------------

The best performing signatures obtained from each human dataset, assessed by k-fold validation, are presented in [Table 2](#T2){ref-type="table"}. Although four human radiation datasets were available, GSE701 contained only 10 samples, which was insufficient for derivation of a unique gene signature. While k-fold validation removes the requirement for inter-dataset normalization, it assesses the ability of signatures (genes) to predict radiation exposure without tying the signatures to corresponding models. Each signature is characterized by the feature selection algorithm and its validation statistics, which have been averaged over the 3 independent datasets that were excluded from the original data used to derive the signature.

###### Best human signatures assessed by K-Fold validation.

  -------------------------------------------------------------------------------------------------------------------------------
  Signature ( *C*, )                                                                    FS\     Average\    Average\   Average\
                                                                                        Algo.   Misclass.   Log Loss   GoF
  ------------------------------------------------------------------------------------- ------- ----------- ---------- ----------
  **a) Derived from GSE1725 and K-Fold Validated on GSE10640\[GPL6522\] (n = 85),**\                                   
  **GSE6874\[GPL4782\] (n = 78), and GSE701 (n = 10)**                                                                 

  *GADD45A DDB2* (1, 1)                                                                 FSFS    0.07        0.40       24

  *PPM1D DDB2 CCNF CDKN1A PCNA GADD45A PRKAB1 TOB1 TNFRSF10B MYC*\                      CSFS    0.07        0.18       14
  *CCNB2 PTP4A1 BAX CCNA2 ATF3 LIG1 CCNG1 FHL2 PPP1R2 MBD4 RASGRP2*\                                                   
  *UBC NINJ1 TRIM22 IL2RB TP53BP1 PTPRCAP EEF1D PTPRE RAD23B EIF2B4 STX11*\                                            
  *PTPN6 STK10 PSMD1 BTG3 MLH1 RNPEP HSPD1 UNG PTPRC PTPRA BCL2 GSS*\                                                  
  *SH3BP5 TPP2 IDH3B CCNH STK11 EIF4EBP2 HSPA4 FADS2 RPA3 GZMK ANXA4*\                                                 
  *ICAM1 PPID LMO2 PPIE NUDT1 FUS POLR2A LY9 RPA1 PTS TNFRSF4 RPA2 PSMD8*\                                             
  *GCDH MAN2C1 PTPN2 RUVBL1 ATP5H GK CD79B MAP4K4 POLE3 PRKCH AKT2*\                                                   
  *MOAP1 CCNG2 ALDOA SRD5A1 HAT1 XRCC1 EIF2S3 RAD1 UBE2A ZFP36L1 CD8A*\                                                
  *TALDO1 GPX4 SSBP2 ERCC3 ATP5O PEPD EIF4G2 ACO2 HEXB UBE3A ARPC1A*\                                                  
  *PSMD10 PRCP PPIB ZNF337 CETN2 RPL29* (10000, 10000)                                                                 

  **b) Derived from GSE10640\[GPL6522\] and K-Fold Validated on GSE1725 (n = 114),**\                                  
  **GSE6874\[GPL4782\] (n = 78), and GSE701 (n = 10)**                                                                 

  *DDB2 RAD17 PSMD9 LY9 PPIH PCNA MDH2 MOAP1 TP53BP1 PPM1D ATP5G1*\                     BSFS    0.05        0.39       15
  *BCL2L2 ENO2 PTP4A1 PSMD8 LIG1 FDPS OGDH CCNG1 PSMD1* (100, 100)                                                     

  *DDB2 HSPD1 ICAM1 PTP4A1 GTF3A LY9* (100000, 10000)                                   FSFS    0.08        0.16       43

  *RAD17 TNFRSF10B PSMD9 LY9 PPIH PCNA ZNF337 MDH2 TP53BP1 PPM1D*\                      BSFS    0.05        0.22       11
  *ZFP36L1 ATP5G1 ALDOA BCL2L2 ENO2 GADD45A PTP4A1 PSMD8 LIG1 ATP5O*\                                                  
  *FDPS OGDH PSMD1* (10000, 10000)                                                                                     

  **c) Derived from GSE6874\[GPL4782\] and K-Fold Validated on GSE1725 (n = 114),**\                                   
  **GSE10640\[GPL6522\] (n = 85), and GSE701 (n = 10)**                                                                

  *DDB2 PRKDC PRKCH IGJ* (100000, 10000)                                                FSFS    0.02        0.27       7

  *DDB2 PRKDC TPP2 PTPRE GADD45A* (1000, 100)                                           FSFS    0.02        0.07       5
  -------------------------------------------------------------------------------------------------------------------------------

Since traditional validation typically requires separate training and test sets that feature samples irradiated at the same exposure levels, only signatures derived from GEO: GSE6874\[GPL4782\] and GEO: GSE10640\[GPL6522\] could be analyzed. [Table 3](#T3){ref-type="table"} presents the best human signatures according to this validation approach. This type of external validation is the most challenging due to the variability associated with different microarray experiments and batch effects of different platforms. This potentially explains the lower performance obtained by traditional validation ( [Table 3](#T3){ref-type="table"}) compared with k-fold validation on the same datasets ( [Table 2](#T2){ref-type="table"}). The remaining human signatures are described in [Supplementary Files Y1--Y5](#SF2){ref-type="other"}.

###### Best performing human signatures assessed by traditional validation.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Signature ( *C*, σ)                                                                    FS\     FS\           FS Log\       Validation\   Validation\   Validation\
                                                                                         Algo.   Misclass.     Loss          Misclass.     Log Loss      GoF
  -------------------------------------------------------------------------------------- ------- ------------- ------------- ------------- ------------- -------------
  **a) Derived from GSE10640\[GPL6522\] and Validated on GSE6874\[GPL4782\] (n = 78)**                                                                   

  *DDB2 HSPD1 MAP4K4 GTF3A PCNA MDH2*\                                                   FSFS    N/A           2.0E-14       0.14 ± 0.00   0.70 ± 0.03   25 ± 0
  (1000, 10)                                                                                                                                             

  *DDB2 GTF3A TNFRSF10B* (1, 1)                                                          0.07    0.20 ± 0.03   0.51 ± 0.00   35 ± 5                      

  **b) Derived from GSE6874\[GPL4782\] and Validated on GSE10640\[GPL6522\] (n = 85)**                                                                   

  *DDB2 CD8A TALDO1 PCNA EIF4G2 LCN2*\                                                   BSFS    N/A           0.42          0.08 ± 0.00   0.41 ± 0.00   14 ± 0
  *CDKN1A PRKCH ENO1 PPM1D*\                                                                                                                             
  (10000, 1)                                                                                                                                             

  *DDB2 CD8A TALDO1 PCNA LCN2 CDKN1A*\                                                   0.08    N/A           0.12 ± 0.00   0.31 ± 0.00   21 ± 0        
  *PRKCH ENO1 GTF3A IL2RB NINJ1 BAX TRIM22*\                                                                                                             
  *PRKDC GADD45A MOAP1 ARPC1B LY9 LMO2*\                                                                                                                 
  *STX11 TPP2 CCNG1 GABARAP BCL2 GSS*\                                                                                                                   
  *FTH1* (10000, 1000)                                                                                                                                   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------

To determine which human genes are most consistently selected, the most frequently appearing genes (11 or 12 depending on number of equally prevalent genes in different signatures) were compiled from the top 20 human signatures (assessed by lowest average log loss during k-fold validation) from GSE10640\[GPL6522\], GSE6874\[GPL4782\], and GSE1725. The union of these three lists indicates the relative frequencies of each gene ( [Figure 6](#f6){ref-type="fig"}). [Figure 7](#f7){ref-type="fig"} visualizes the mutual information of gene expression ( [Figure 6](#f6){ref-type="fig"}) shared with radiation dose.

![Heat map depicting the gene compositions of the top 20 human signatures derived at different radiation doses: 150-200 cGy (GSE10640\[GPL6522\], GSE6874\[GPL4782\]) and 500 cGy (GSE1725).\
Frequencies are first scaled within and then between datasets to ensure values between 0 and 1.](f1000research-7-16666-g0005){#f6}

![Scatter plot depicting the mutual information each gene's expression shares with radiation exposure (averaged over GSE10640\[GPL6522\], GSE6874\[GPL4782\], and GSE1725).\
The size of each circle is proportional to the frequency at which the gene appears in the top 20 human signatures ranked by average validation log loss from GSE10640\[GPL6522\], GSE6874\[GPL4782\], and GSE1725. The genes shown are also are the same as those indicated in [Figure 6](#f6){ref-type="fig"}.](f1000research-7-16666-g0006){#f7}

While most genes have similar representation in signatures derived from different datasets, *GADD45A* and *DDB2*, in particular, are significantly more frequent in those derived from GSE1725 and GSE10640\[GPL6522\]. *GADD45A* and *DDB2* are present in signatures derived from samples irradiated at different exposures ( *GADD45A* -- 500 cGy, *DDB2* -- 150-200 cGy). This raises questions as to whether these genes have a larger influence on the accuracy of individual signatures and whether their expression is calibrated to radiation exposure levels. Removal of these gene features was performed to address their impact. Genes of interest have been removed from each of the top 20 human signatures derived from various datasets and then the signatures were revalidated excluding these features ( [Table 4](#T4){ref-type="table"}). The difference between the validation metrics preceding and following removal of a gene represents the weight of the gene within a signature. Δ *MC*, Δ *LL*, and Δ *GoF* represent the changes in misclassification, log loss, and goodness of fit, respectively.

###### Effect of removing genes from signatures of different datasets.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  GSE1725 Validation\                                                                                GSE10640 Validation\   GSE6874 Validation\                GSE701 Validation\   Average                                                                                                      
  (0 vs 500 cGy)                                                                                     (0 vs 150-200 cGy)     (0 vs 150-200 cGy)                 (300 vs 700 cGy)                                                                                                                  
  -------------------------------------------------------------------------------------------------- ---------------------- ---------------------------------- -------------------- --------- ---------------------------------- -------- ------- ------- ------- ------- ------ ------- ------- -------
  **a) Removal of *GADD45A* from signatures derived from GSE1725**                                                                                                                                                                                                                               

  0.446                                                                                              0.008                  N/A [\*](#fn3){ref-type="other"}   0.367                0.373     61.1                               0.111    0.561   19.4    0.353   0.529   247    0.319   0.368   109

  **b) Removal of *GADD45A* from signatures derived from GSE10640\[GPL6522\]**                                                                                                                                                                                                                   

  0.001                                                                                              0.011                  0.658                              0.001                0.237     N/A [\*](#fn3){ref-type="other"}   -0.007   0.008   -1.29   0.043   1.45    29.8   0.010   0.427   9.72

  **c) Removal of *DDB2* from signatures derived from GSE10640\[GPL6522\]**                                                                                                                                                                                                                      

  0.128                                                                                              0.166                  64.2                               0.078                0.211     N/A [\*](#fn3){ref-type="other"}   0.103    0.157   17.9    0       0.471   0      0.08    0.251   27.4

  **d) Removal of *DDB2* from signatures derived from GSE1725**                                                                                                                                                                                                                                  

  0.012                                                                                              0.044                  N/A [\*](#fn3){ref-type="other"}   0.069                0.367     0.102                              0.153    0.202   0.269   0.003   0.715   2      0.059   0.332   0.790

  **e) Removal of *BAX* (control for *GADD45A*) from signatures derived from GSE1725**                                                                                                                                                                                                           

  N/A [\*\*](#fn4){ref-type="other"}                                                                 0.08                   N/A [\*](#fn3){ref-type="other"}   0.024                0.478     0.989                              0.025    0.025   4.37    0.005   0.006   3.5    0.018   0.147   2.95

  **f) Removal of *PRKAB1* (control for *DDB2*) from signatures derived from GSE10640\[GPL6522\]**                                                                                                                                                                                               

  N/A [\*\*](#fn4){ref-type="other"}                                                                 0.001                  N/A [\*](#fn3){ref-type="other"}   0.011                0.048     5.70                               -0.01    0.01    -2.47   0.02    -0.04   14     0.007   0.005   5.74
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* *∆*GoF is always N/A for the dataset used to derive signatures because GoF is never used as the optimized metric during signature development (see Feature Selection Algorithms section under Methods).

\*\*Unavailable because the top 20 human signatures derived from GSE1725 were all obtained by optimizing log loss rather than misclassification.

*GADD45A* appears in 14 of the top 20 signatures derived from GSE1725. Of the 14 signatures, 10 were single gene signatures, as *GADD45A* alone was expected to sufficiently distinguish irradiated from unirradiated samples. In these cases, it was assumed that a null signature would perform as well as a predictor that randomly draws predictions from a uniform distribution of doses. Removal of *GADD45A* from these 14 signatures, results in an average increase in misclassification, log loss, and goodness of fit by 0.319, 0.368, and 109 cGy, respectively (see [Table 4a](#T4){ref-type="table"}). In contrast, elimination of *BAX*, which only appears in 2 of the top 20 signatures derived from GSE1725 and results in an average increase in misclassification, log loss, and goodness of fit by 0.018, 0.147, and 2.95 cGy respectively ( [Table 4e](#T4){ref-type="table"}). Comparing the effects of removing *DDB2* ( [Table 4c](#T4){ref-type="table"}) and *PRKAB1* ( [Table 4f](#T4){ref-type="table"}) from the top 20 GSE10640\[GPL6522\] signatures confirms the impact of genes that frequently occur within the most accurate gene signatures.

However, the diagnostic contributions of *GADD45A* and *DDB2* expression to the radiation levels at which samples were exposed (500 cGy and 150-200 cGy respectively) are confounding. The effects on model performance resulting from removal of *GADD45A* from the GSE10640\[GPL6522\] signatures ( [Table 4b](#T4){ref-type="table"}) versus the GSE1725 signatures ( [Table 4a](#T4){ref-type="table"}) are discordant. Δ *MC* is higher when *GADD45A* is removed from GSE1725, but Δ *LL* is higher when *GADD45A* is removed from GSE10640\[GPL6522\]. Δ *LL* is large when *GADD45A* is removed from both datasets, which is consistent with the importance of *GADD45A* at both radiation doses. Indeed, *GADD45A* expression has been demonstrated to be rapidly induced by radiation levels as low as 2 Gy ^[@ref-47]^. Similar discordance was observed in the feature removal experiments of *DDB2* ( [Table 4c, 4d](#T4){ref-type="table"}).

As was the case with murine signatures, genes appearing in the best human signatures do not necessarily share high mutual information with radiation dose. However, the compositions of the human signatures are dominated by four genes, *DDB2*, *GADD45A*, *PCNA*, and *PPM1D*, which all share a lot of information with radiation dose ( *DDB2*: 0.55, *GADD45A*: 0.39, *PCNA*: 0.51, *PPM1D*: 0.46). The functions associated with these and less frequently appearing genes are depicted in [Figure 8](#f8){ref-type="fig"} ^[@ref-46]^. The pathways and functions represented include keratinocyte differentiation ( *PRKCH* ^[@ref-9]^), induction of apoptosis ( *BCL2L* ^[@ref-37]^ and *BAX* ^[@ref-36]^), DNA repair ( *TP53BP1* ^[@ref-29]^, *RAD17* ^[@ref-30]^, *DDB2* ^[@ref-24]^, *PRKDC* ^[@ref-29]^, and *PCNA* ^[@ref-33]^), actin nucleation ( *ARPC1B* ^[@ref-28]^), and regulation of JNK-p38 ( *MAPK14*) signalling ( *GADD45A* ^[@ref-33]^ and *PPMD1* ^[@ref-33]^). The four common genes belong to the DNA repair and regulating JNK-p38 ( *MAPK14*) pathways, which may imply particular significance to these functions in human response to radiation exposure. Interestingly, GADD45A and PPMD1 are antagonistic, that is, GADD45A activates while PPMD1 inhibits p38.

![Depiction of major cellular functions of most frequently appearing genes of the best human signatures (see [Figure 5](#f5){ref-type="fig"} and [Figure 6](#f6){ref-type="fig"}).](f1000research-7-16666-g0007){#f8}

Validating gene signatures on partial body irradiated samples
-------------------------------------------------------------

We also evaluated the total body irradiation human signatures with expression data from baboons (GSE77254) that were exposed to partial body irradiation. All signatures derived from human samples (see [Supplementary Files Y4 and Y5](#SF2){ref-type="other"}) were completely contained in this dataset and so were eligible for validation. The signatures chosen contained all datapoints, circumventing the need to perform nearest neighbour imputation. Paralogous baboon genes were cross-referenced with those that were used to derive human signatures and expression values of multiple probes within the same gene were averaged.

Signatures were used to differentiate between various label combinations: (1) unirradiated vs. 1 day post-irradiation, (2) unirradiated vs. 2 day post-irradiation, (3) 1 vs. 2 day post-irradiation, (4) unirradiated vs. 1° and 2° HARS, (5) unirradiated vs. 2° and 3° HARS, and (6) 1° and 2° HARS vs. 2° and 3° HARS. [Supplementary Files Z1 and Z2](#SF3){ref-type="other"} contain validation results based on baboon expression data with human signatures.

Multiple Y4 signatures achieved 0% misclassification in distinguishing unirradiated samples from radiated samples (above label combinations 1, 2, 4, and 5) and multiple Y5 signatures achieved 0% misclassification in label combinations 1, 2, and 5. However, the best performing signatures on this dataset were not the best performing signatures obtained during validation on GSE6874 (Y4) and GSE10640 (Y5). We speculate that technical factors involved in the study design explain why signatures performed differently. For example, the human signatures were derived from blood samples that were collected 6--24 hours after exposure whereas the baboon blood samples were obtained 24--48 hours after exposure. Also, a different microarray platform was used to obtain expression values for the baboon samples.

We also investigated total body radiation signatures on predicting exposures with different sources of partial body irradiation expression data: GSE66372 ^[@ref-48]^ and GSE84898 ^[@ref-49]^. These murine and baboon datasets lacked several genes present in the signatures we derived. None of the Y4 and Y5 signatures were completely contained in GSE66372; the *PSMD9* single gene signature was the only human signature that was completely contained in GSE84898. However, the *PSMD9* signature has poor performance among Y5 signatures based on its log loss metric on GSE6874.

Discussion
==========

Biochemically inspired genomic signatures of human and murine radiation response exhibit high accuracies in validating independent datasets (98% in k-fold validation, 92% by traditional methods). Some of the human signatures exhibit among the highest specificities reported (e.g. the signature *DDB2*, *CD8A*, *TALDO1*, *PCNA*, *EIF4G2*, *LCN2*, *CDKN1A*, *PRKCH*, *ENO1*, *PPM1D*) exhibited 92% accuracy when validated on GSE10640\[GPL6522\]. This dataset contains both radiation therapy patients (150--200 cGy) and controls (0 cGy) which include healthy donors and chemotherapy patients treated with alkylators ^[@ref-9]^. Thus, the signature distinguished radiation-induced and chemotherapy-associated DNA damage.

Some of the best performing signatures consisted of one to three gene features. The first signature in [Table 2](#T2){ref-type="table"} contains *GADD45A* and *DDB2*, and exhibits a misclassification error rate of 7%. These relatively short signatures have certain advantages over longer signatures with similar performance. It is more likely that the model can be generalized to a wider spectrum of data, when fewer features are required, and from a practical standpoint, diagnostic tests based on fewer gene expression measurements are less susceptible to experimental error.

*BAX*, an inducer of apoptosis, was the single gene shared among those frequently appearing in both murine and human signatures. One possible explanation for this is that the mouse datasets featured samples irradiated at four levels while human datasets contained samples irradiated at two levels. Genes selected by multi-class model algorithms may better discriminate radiation dose. Nonetheless, the radiation response pathways of mice are not necessarily similar to those of humans. In fact, Lucas *et al*. have shown that the murine signatures they developed are not translatable to human samples ^[@ref-50]^. Furthermore, only two genes, including *BAX*, are shared by the human and murine signatures derived by Dressman *et al*. ^[@ref-50]^.

None of the samples exposed to ≥200 cGy are misclassified below this radiation dose based on the multi-class murine signatures ( [Figure 5](#f5){ref-type="fig"}). In the future, a similar analyses could be performed in clinical studies of human subjects exposed to different radiation levels, which might prove useful for determining treatment eligibility after exposure to high levels of myelosuppressive radiation ^[@ref-51]^.

A comparison of the most frequently appearing genes in the optimal human ( [Figure 6](#f6){ref-type="fig"}) and mouse signatures ( [Figure 2](#f2){ref-type="fig"}) with signatures previously derived in other studies reveals little overlap ( [Table 5](#T5){ref-type="table"}). The compositional differences can be attributed to types of samples used for model training, microarray platforms used, and feature selection techniques used in deriving signatures. However, genes consistently selected in optimized signatures in at least three independent studies include *BAX*, *DDB2*, *GADD45A*, *LY9*, and *TRIM22*. Expression of these genes is indeed predictive of radiation dose and not a result of noise in individual datasets. An ensemble signature consisting of these genes achieves up to 92.3% accuracy in k-fold validation over 277 samples and up to 81.2% accuracy in traditional validation over 78 samples. The quality of the gene signature is largely determined by the quality and amount of training data used to fit the SVM model. Thus, this level of accuracy is not the upper bound on the performance of an SVM of the ensemble signature. Additional data at exposures with fixed levels of radiation in matched training and testing samples could improve model performance.

###### Genes found in best performing signatures and previously derived signatures.

  ---------------------------------------------------------------------------------------------------------------------------------
  Prior Studies                    Validation Performance   Shared Genes in Signatures         
  -------------------------------- ------------------------ ---------------------------- ----- ------------------------------------
  Dressman *et al*.\               90%                      N/A                          N/A   *BAX*, *DDB2*, *PRKCH*
  (human) ^[@ref-9]^                                                                           

  Dressman *et al*.\               N/A                      N/A                          N/A   *Bax*, *Cd72*, *Cd79b*, *Cdkn1a*,\
  (mouse) ^[@ref-9]^                                                                           *Ei24*, *Galt*, *Glipr2*, *Ly6d*,\
                                                                                               *Ms4a1*, *Tfam*

  Paul *et al*.\                   98%                      N/A                          N/A   *BAX*, *DDB2*, *GADD45A*, *LY9*,\
  (human) ^[@ref-10]^                                                                          *PCNA*, *PPM1D*, *PTP4A1*,\
                                                                                               *RASGRP2*, *TRIM22*

  Lu *et al*. (human) ^[@ref-7]^   \~90%                    86%                          N/A   *DDB2*, *FHL2*, *GADD45A*, *LY9*,\
                                                                                               *TRIM22*

  This study (human)               100%                     98%                          92%   N/A

  This study (mouse)               99%                      92%                          N/A   N/A
  ---------------------------------------------------------------------------------------------------------------------------------

Ensemble models should be considered which combine genes discovered in different well-performing signatures. Although the most frequently represented human and murine genes were compiled, genes common to one dataset did not appear equally frequently in signatures from the other. This discordance may possibly result of noise in the different datasets, or perhaps to intrinsic differences between them. Compilation of frequently appearing genes in different datasets may be useful for discovery of consistently represented genes that are incorporated into high-performance signatures.

The types of data available for this study and the analytical approaches we used potentially limited the interpretation of these gene signatures. Blood samples of mouse and human datasets were all collected within 24 hours of exposure. Thus, signatures derived on these datasets may only be valid in white blood cells with a limited time window (\<24 hours). Additionally, one of the datasets we used to derive signatures, GSE6874, appears to have been a particularly noisy dataset, based on the average misclassification rates on GSE10640, GSE1725, and GSE6874 of 0.03, 0.02, and 0.11, respectively. Assuming that it is possible to differentiate samples irradiated at different levels of exposure using expression data, the feature selection misclassification metric estimates the theoretical limit of how well differentially irradiated samples can be separated based on expression. The surprisingly high feature selection misclassification values obtained from GSE6874 may therefore be indicative of greater levels of noise in the data. Lastly, the greedy feature selection algorithms used to derive signatures cannot guarantee optimal results, that is, we cannot confirm that we have found the best possible signatures from each dataset for predicting radiation exposure. This potentially explains the discordance in gene composition between murine datasets ( [Figure 2](#f2){ref-type="fig"}).

Nevertheless, the validation performance of radiation signatures is significantly improved ( [Table 5](#T5){ref-type="table"}). The signatures that were externally k-fold validated achieved nearly 100% accuracy. Some of our human signature models are also externally validated in the traditional sense (i.e. using a single model). This validation method, which is representative of an actual scenario, achieves \>90% accuracy, and is directly relevant to creating a routine, efficient and highly accurate expression-based radiation prognostic assay.

Data availability
=================

The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2018 Zhao JZL et al.

Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication). <http://creativecommons.org/publicdomain/zero/1.0/>

All data underlying the results are available as part of the article and no additional source data are required.

ZENODO: Matlab code for "Predicting Exposure to Ionizing Radiation by Biochemically-Inspired Genomic Machine Learning", [doi: 10.5281/zenodo.1170572](http://dx.doi.org/10.5281/zenodo.1170572) ^[@ref-52]^

Code is available under the terms of the [Creative Commons Attribution 4.0 International license](https://creativecommons.org/licenses/by/4.0/legalcode) (CC-BY 4.0).

Supplementary material
======================

**Supplementary File X: This spreadsheet lists all the genes found from our literature search (see Methods) that were considered during feature selection.** For each gene, we report the reason for inclusion and a link to the paper containing the supporting evidence.

Click here for additional data file.

**Supplementary Files Y1--Y7: These files contain information concerning all the total body radiation signatures derived for this paper.** Each file contains the validation results of signatures derived from a particular dataset. Files Y1-Y3 contain the k-fold validation results of human signatures derived from GSE1725, GSE6874, and GSE10640, respectively, while Y4-Y5 contain the traditional validation results of human signatures derived from GSE6874 and GSE10640, respectively. Files Y6-Y7 contain the k-fold validation results of mouse signatures derived from GSE10640\[GPL4783\] and GSE10640\[GPL6524\], respectively. Each supplementary file contains the following columns: Signature, FS Algorithm, C, sigma, FS Misclassification, FS Log Loss, K, Misclassification, Misclassification Error, Log Loss, Log Loss Error, Goodness of Fit, and Goodness of Fit Error. These headings are described in the tab titled "Legend" in Files Y1-Y7. In addition, Files Y1-Y3 have three extra columns: Average Misclassification, Average Log Loss, and Average Goodness of Fit, which represent the misclassification, log loss, and goodness of fit, respectively, averaged over all validation sets.

Click here for additional data file.

**Supplementary Files Z1--Z2: These files contain results concerning tradiation validation of Y4 and Y5 human signatures on partial body radiation exposed primates.** Different comparison groups described in the text are indicated in separate tabs in each File. Table headings correspond to performance metrics shown for signatures Y4 and Y5.

Click here for additional data file.
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Version 1

**Summary**

In this study, the authors have identified gene signatures for radiation dose prediction using machine learning methodologies based on publically available microarray results from human and murine samples (mostly lymphocytes) exposed to ionizing radiation. Their signatures have been independently validated showing a high specificity for dose estimation. The authors have used a novel method, based on the concept of minimum redundancy maximum relevance. This generated signatures which often contained genes that had not previously been identified as potential radiation biomarkers. In all, this is a well-conducted study with relevance to the field. However, we do have some comments/questions/remarks, as outlined below.

**Introduction** Several other studies have applied machine learning methodologies to identify predictive radiation exposure biomarkers. Some of these have been reviewed in Hall *et al*., Mut Res 2017, Supplementary Table 3.5.1.1.Another important aspect of gene expression is alternative splicing, which also occurs in response to ionizing radiation (e.g. Sprung *et al.*, PLoS ONE 2011; Forrester *et al.*, PLoS ONE 2012; Macaeva *et al.,* Sci Rep 2016). The latter study also showed for the first time the suitability of exon signatures as sensitive radiation biomarkers, and highlights the importance of prior knowledge at the exon level for subsequent primer- or probe-based assays (e.g. qRT-PCR). This may be discussed.  

**Methods** In the data Pre-processing "Rows and columns of microarray data that are less than 95% complete were removed and any remaining missing values were imputed using the nearest-neighbor algorithm" How many rows and columns were removed, and on which basis was the 95% threshold selected. Also, what is the effect of the nearest-neighbor algorithm on the data \"over-fitting\". Is it possible to perform PCA on the data after removing any row/columns with less than 100% completeness and compare to the currently presented approach (95% removal and filling the remainder of the missing data)? This would allow the visualization of the effect of the proposed methodology on the segregation between the various records.Only genes common to all datasets were retained. Does that mean common between mouse and human datasets? How were aliases identified?The second step in the process is the selection of genes based on a non-exhaustive list of publications. Why was this necessary if the mRMR method for feature selection was applied?I particularly like the idea of performing quantile normalization after feature selection. Is this something that has been published before? Can the authors speculate (or maybe even compare) about the performance of their method on pre-normalized datasets?Concerning the method used for the "Validation of models", I would think this approach would be more vulnerable towards the test/training dataset. What would occur to the accuracy when doing the normalization over-all of the data? Would the accuracy change drastically? Is it possible to extend the testing to cover additional data?Many datasets exist on human PBMCs/whole blood irradiated with a range of doses. Why were these datasets not considered for this study while lymphoblastoid cell lines were?It would be helpful to have a comparison of model performance with that of "traditional" machine learning methods, as used in some of the indicated references.  

**Results** "We discovered radiation gene signatures using the microarray data of human and mouse peripheral blood samples and human lymphoblastoid cell lines, which were validated either according to signature." Were the human lymphoblastoid cell line and prepheral blood samples grouped together in one model? If so, would it be possible to visualize how the expression data of the shortlisted genes for each data type separately (using PCA for example)?Can the authors comment on their observation that signatures derived from both murine datasets are not very similar? Apart from "noise, or intrinsic differences in the datasets", could it possibly also be a consequence of the method used, i.e. mRMR in which low mutual information genes are selected? Based on Fig. 2 and 6 it seems that genes with higher mutual information in general have higher frequencies. Which seems logical.The authors state that Ms4a1 appears less frequently than Glipr2. However, from the sizes of the circles, Ms4a1 seems to appear more frequently than Glipr2. Please verify this statement.Are genes in Tables 1 and 2 ranked according to their frequency, importance,...?How do the authors explain the low frequencies of human signature genes (Fig. 6), compared with murine (Fig. 2)?Likewise, can the authors explain the large number of genes with low mutual information in the human signature (23 out of 26 \<0.4), compared with the murine signature (4 out of 33 \<0.4).Although I like the idea of mRMR, it is somewhat counterintuitive to have genes with little mutual information to be important for dose prediction. This seems to be confirmed by the fact that the compositions of human signatures are dominated by genes with high mutual information (in fact, these are all well known p53-dependent genes which appear in a high number of published radiation signatures).  

**Discussion** I understand the advantage of small signatures in terms of practicality. However, in case of a real emergency, in which individuals have been irradiated without good knowledge about the exact time since exposure, larger gene signatures may provide the additional benefit of having different dynamics per gene. This may help to also predict not only the dose, but also the time since exposure. Furthermore, one-gene signatures may suffer from higher variability among the population compared to larger gene signatures.I believe results from other, similar studies may be briefly situated in the introduction/discussion.

We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Rogan

Peter

University of Western Ontario, Canada

**Competing interests:**No competing interests were disclosed.
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Regarding other studies that identify predictive radiation exposure biomarkers, we have now added text citing these and other studies in  paragraph 1 of the introduction of version 2 of our paper.We investigated whether alternative splicing in response to ionizing radiation might affect the expression values that were used in training or validation of machine learning models we derived. These values could theoretically be distorted if the hybridization probes used to quantify gene expression in these microarray data were predominantly located in cassette exons. We carefully analyzed the probes on one of the most prominent genes in our signatures: *DDB2*, which consists of 10 exons in total. Out of the three human datasets used for deriving signatures, GSE6874\[GPL4782\] lacked information about the location of its *DDB2* probe. However, the *DDB2* probes in GSE10640\[GPL6522\] and GSE1725 were located in exons 8-10. According to UCSC Genome browser, the only transcript variants (NM_001300734.1, mRNA AB107039, and mRNA BC050455) involved skipping or fusing exons 3-7. Thus, in this case, alternative splicing does not affect our results, since the *DDB2* probes avoid alternatively spliced exons. In general, probes seem to be designed to avoid alternatively spliced regions. Although we have not verified this for all the genes in our signatures, we speculate that taking an average over multiple probes reduces any potential affect of alternative splicing.The nearest neighbor analysis was performed to avoid inclusion of genes or individuals with sparse data in the analysis. We conservatively selected  a threshold of 95% completeness to ensure that the original source data were reliable. At this threshold, none of the  rows or columns or each of the datasets we used for deriving signatures (GSE1725, GSE6874\[GPL4782\], GSE10640\[GPL6522\], GSE10640\[GPL4783\], GSE10640\[GPL6524\]) were removed (based on genes common among all datasets). The effect of nearest neighbours on overfitting was  minimal. Upon restriction to the set of genes available for feature selection, there were no missing values in GSE1725 and GSE6874\[GPL4782\], a single missing value in GSE10640\[GPL6524\] and GSE10640\[GPL6522\], and 62 missing values in GSE10640\[GPL4783\]. However, in GSE10640\[GPL4783\], of the genes available for feature selection, only four genes contained at least one missing expression value: *Rad51*, *Ptpre*, *Gadd45a*, and *Pola1*. None of these genes are among the 33 most frequently appearing genes of our murine signatures (see Figure 2). (Recall that GSE10640\[GPL4783\] is a murine dataset). Additionally, overfitting is mitigated by validation using independent datasets. The nearest neighbor source data occurs before model development, so the model is not fit at that point.Regarding the questions about genes common to all datasets being retained: 1) Mouse and human signatures were derived separately. So only genes common to all human datasets were available for selection in deriving human signatures and only genes common to all mice datasets were available for selection in deriving mouse signatures. 2) Our scripts did not take gene name aliases into account. It is therefore possible that genes that were left out of the analysis because they were indicated by different names in different datasets.The initial list of publications we consulted may not have been complete, but it was the result of an extensive search.  We were concerned that mRMR method applied to all genes without independent experimental support would result in Type II errors. We wanted to identify the key genes from the large volume of peer-reviewed work implicating various genes in radiation response. This hypothesis based study was not designed to discover novel genes, whose putative role in radiation response was unproven or unknown. We have automated the initial feature selection procedures using expression of all (including non-coding) genes, but this is beyond the scope of our efforts.  The discovery strategy would require statistical correction for the likelihood of incorrectly rejecting a null hypothesis due to multiple comparison testing.Regarding quantile normalization after feature selection, this is the first time that we have used this approach.  We attempted this because our initial efforts to derive signatures from pre-normalized data were unsuccessful (poor performance). Since we do not use the expression values for the majority of genes, there was no compelling reason to   normalize across the entire set of expressed genes. We are not aware of other previous efforts, but cannot exclude this possible. We did not perform an exhaustive literature search for the method that we employed, since the universe of potential applications is nearly limitless.We speculate that if quantile normalization is done *before*feature selection, then the reduction in dynamic range in the transformed data may  lead to the derivation of poorer signatures.To give a more quantitative answer, we took the top performing signature in the Y5 Supplementary file with respect to log loss ( *DDB2 GTF3A* *TNFRSF10B*) and re-validated with normalization over all data instead of just over genes in the signature; misclassification error was 2% higher and the goodness of fit was 4 cGy higher (log loss remained approximately the same). Interestingly, normalization performed over all of the data does not appear to have significant effects on the performance of our signatures. To "extend the testing to cover additional data," it would be necessary to renormalize the initial set of genes to include these "additional genes". If no other genes are to be included, only additional samples, then the expression values of the additional samples would need to be renormalized.Regarding other human datasets of irradiated PBMCs, in the feature selection stage, we specifically required datasets with large numbers of samples. The three human datasets we used for feature selection (GSE6874, GSE10640, GSE1725) were the largest ones we found deposited in GEO. In particular, GSE1725, the dataset with cell lines derived from patients, was the largest dataset available to us, containing 110 samples (171 samples in total, but 61 are UV irradiated). At the earliest stage of our project, we specifically chose datasets that maximized the number of common genes represented among them. This requirement enabled us to validate our signatures by either traditional or k-fold approaches.   Genes available for feature selection must be present in all datasets in order for validation to work.  We were surprised to find many datasets where key genes in our models were missing from expression data (see the last section on partial body irradiation data analysis in the results section of the revised version 2 of this paper).Regarding comparison of model performance with other traditional machine learning methods, we have used these methods (eg. random forest, SVMs, decision trees) in previous gene expression studies (see reference 13 of version 1 which is reference 18 of version 2). The improved performance we describe here cannot be attributed to the specific model building approaches.Regarding grouping of lymphoblastoid and PBL samples, models were always trained on one dataset at a time; they were not combined.The dissimilarity of the murine datasets may be related to their use of different microarray platforms and were collected at different times. It is difficult to tease out the intrinsic differences of the datasets from the performance of the methods.Regarding Ms4a1 and Glipr2, we verify the reviewers\' observation. We corrected the density plot during preparation of the paper, but inadvertently neglected to make the corresponding change to the text.  We have replaced *Glipr2* with *Ccng1* or *Eif2ak4*.Regarding ranking of genes in Tables 1 and 2,  signatures derived using BSFS and CSFS list the genes according to mRMR rank. For signatures derived using FSFS, the genes would be listed according to the order in which they were selected. So in this sense, they are indeed ranked according to importance.Regarding the low frequencies of human vs murine signature genes, in the descriptions of these figures, we mention that "Frequencies are first scaled within and then between datasets to ensure values between 0 and 1." Human signature gene frequencies appear suppressed because *DDB2* and *GADD45A* in particular were represented more frequently than any other gene by a large margin.Regarding the numbers of genes with low mutual information in the human vs murine signatures, it may be relevant that expression data are not adjusted for either white blood cell count or body mass. We speculate that the gene expression response in the human samples reflects lower numbers of radiation exposed cells. This could dampen the signals and mutual information with radiation dose compared to the murine response.Regarding the idea that it would be counterintuitive to have genes with low mutual information as important for dose prediction, it is true that signatures are dominated by genes whose expression values share high mutual information with dose. The purpose of mRMR is to make sure that we do not overlook the genes whose expression values may encode information that is not present in the genes whose expression values have high mutual information with dose, which is why sometimes genes with lower mutual information may appear as frequently or even a bit more frequently than genes with higher mutual information.Regarding the single gene signature results, we agree that single gene signatures are more susceptible to extrinsic sources of variation unrelated to radiation exposure. However, simpler signatures may be necessary under laboratory conditions that limit the amount or complexity of testing, e.g. space radiation assays performed by astronauts.
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The authors are absolutely correct that in the event of a radiological accident blood is likely to be the most likely source for analytical materials that would reflect a radiation exposure. Given the analytical approach taken we tested this using two sets of data from normal human lung epithelial cells (HBECs) irradiated at multiple doses by γ-rays but also with Fe particles such as those found in the deep space environment. (Reference 8 in this manuscript)

We were interested in two things: 1) Would the results from lymphoid cells translate to epithelial cells? There is sufficient evidence in the literature to suggest signatures created with lymphoid cells are poor at predicting radio response in cells from tissue. 2) Would the results from γ-ray exposures translate to something more exotic like Fe particles which have discriminating gene sets that are both common to γ-ray and Fe particles as well as unique to the radiation type.

We chose the 10 gene signature derived from GSE6874 and validated against GSE10640. Given the limited size of our sample set, we were surprised to see Prediction Accuracies of 73% for γ-rays and 83% for Fe particle irradiation when examining the normal HBEC cells; and 85 and 76%, respectively, for a genetically manipulated HBEC (p53 knockdown, KRAS mutant over-expressing) cell line.

We look forward to testing this approach in genetically diverse tumor cells.
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Thank you for your efforts  to review our article and evaluate our software. We were excited about the significant results you obtained using the human signature on expression data from irradiated lung epithelial cells, and using the models to detect evidence of Fe particle radiation.
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Well written article. Good analysis of available gene expression data to create gene signatures for ionizing radiation exposure. Good discussion of the identified genes\' functions and roles in radiation response. Conclusions are well supported by the results. Hopefully the analysis and genes identified in this study will be incorporated and/or validated in future studies examining prediction of radiation exposure.
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Thank you for your kind comments. We agree that the approach and software  should be useful for future studies of human radiation exposures. We are particularly motivated to apply multiclass SVMs, which were highly accurate in the murine dataset,  to the analysis of a large set of radiation oncology patients exposed to different radiation doses.

[^1]: **Competing interests:**PKR cofounded CytoGnomix Inc. A patent application on biochemically inspired gene signatures derived by machine learning is pending (US Pat. App. Ser. No. 62/202,796).
